Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

Don’t Forget HPV-45 in Cervical Cancer ScreeningThe Authors’ Reply

(2011) Wiebren A.A. Tjalma et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Genotyping of human papillomavirus in triaging of low-grade cervical cytology

(2011) Anna Söderlund-Strand et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study

(2011) M. Schiffman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting

(2011) F. M. Carozzi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer

(2011) H.-C. Chen et al.   JNCI-Journal of the National Cancer Institute

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

(2011) Hormuzd A Katki et al.   LANCET ONCOLOGY

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

Clinical validation of the Cervista® HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology

(2010) Mark H. Einstein et al.   GYNECOLOGIC ONCOLOGY

Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study

(2010) Koji Matsumoto et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine

(2010) Kevin A. Ault et al.   INTERNATIONAL JOURNAL OF CANCER

Feasibility Study of a Human Papillomavirus E6 Oncoprotein Test for Diagnosis of Cervical Precancer and Cancer

(2010) Johannes Schweizer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

(2010) Laia Bruni et al.   JOURNAL OF INFECTIOUS DISEASES

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants

(2009) S. S. Wang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening

(2009) P. Naucler et al.   JNCI-Journal of the National Cancer Institute

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

HPV Screening for Cervical Cancer in Rural India

(2009) Rengaswamy Sankaranarayanan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of the performance of different HPV genotyping methods for detecting genital HPV types

(2008) Stefanie J. Klug et al.   JOURNAL OF MEDICAL VIROLOGY

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China

(2008) You-lin Qiao et al.   LANCET ONCOLOGY